Trendingnow
Tech

By Nick LichtenbergAugust 30, 2026

Trump backlash adds new risks to the stocks the government owns
By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Carolina Rossini and The ConversationAugust 28, 2026

By Jeffrey C. Dixon and The ConversationAugust 29, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 31 of 100

By Jim EdwardsJuly 1, 2026

By Lily Mae LazarusJuly 1, 2026

By Andrew NuscaJuly 1, 2026

By Marco Quiroz-GutierrezJuly 1, 2026

By Mia OsmonbekovJune 30, 2026

By Jeremy KahnJune 30, 2026

By Wayne BersonJune 30, 2026

By Vinod KhoslaJune 30, 2026

By Ruth UmohJune 30, 2026

By Marc AndersenJune 30, 2026

By Allie GarfinkleJune 30, 2026

By Jim EdwardsJune 30, 2026

By Amanda McMasterJune 30, 2026

By Marco Quiroz-GutierrezJune 30, 2026

By Catherina GioinoJune 29, 2026

By Nick LichtenbergJune 29, 2026

By Nick LichtenbergJune 29, 2026

By Tristan BoveJune 29, 2026

By Sasha RogelbergJune 29, 2026

By Amanda GerutJune 29, 2026

By Camila Grigera NaónJune 29, 2026

By Jason MaJune 29, 2026

By Rod McGuirk and The Associated PressJune 29, 2026

By Steven Sloan and The Associated PressJune 29, 2026

By Michelle Chapman and The Associated PressJune 29, 2026

By Sheryl EstradaJune 29, 2026
Most Popular




















